Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
Harrison, Stephen A., Ruane, Peter J., Freilich, Bradley L., Neff, Guy, Patil, Rashmee, Behling, Cynthia A., Hu, Chen, Fong, Erica, de Temple, Brittany, Tillman, Erik J., Rolph, Timothy P., Cheng, Andrew, Yale, Kitty
Published in Nature medicine (01.07.2021)
Published in Nature medicine (01.07.2021)
Get full text
Journal Article
Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection
Lawitz, Eric J, O'Riordan, William D, Asatryan, Armen, Freilich, Bradley L, Box, Terry D, Overcash, J Scott, Lovell, Sandra, Ng, Teresa I, Liu, Wei, Campbell, Andrew, Lin, Chih-Wei, Yao, Betty, Kort, Jens
Published in Antimicrobial agents and chemotherapy (01.03.2016)
Published in Antimicrobial agents and chemotherapy (01.03.2016)
Get full text
Journal Article
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
Jones, David, Boudes, Pol F, Swain, Mark G, Bowlus, Christopher L, Galambos, Michael R, Bacon, Bruce R, Doerffel, Yvonne, Gitlin, Norman, Gordon, Stuart C, Odin, Joseph A, Sheridan, David, Wörns, Markus-Alexander, Clark, Virginia, Corless, Linsey, Hartmann, Heinz, Jonas, Mark E, Kremer, Andreas E, Mells, George F, Buggisch, Peter, Freilich, Bradley L, Levy, Cynthia, Vierling, John M, Bernstein, David E, Hartleb, Marek, Janczewska, Ewa, Rochling, Fedja, Shah, Hemant, Shiffman, Mitchell L, Smith, John H, Choi, Yun-Jung, Steinberg, Alexandra, Varga, Monika, Chera, Harinder, Martin, Robert, McWherter, Charles A, Hirschfield, Gideon M
Published in The lancet. Gastroenterology & hepatology (01.10.2017)
Published in The lancet. Gastroenterology & hepatology (01.10.2017)
Get more information
Journal Article
A phase II, open label, randomized, noncomparative study of eFT508 (tomivosertib) alone or in combination with avelumab in subjects with relapsed/refractory microsatellite stable colorectal cancer (MSS CRC)
Hubbard, Joleen Marie, Patel, Manish R., Bekaii-Saab, Tanios S., Falchook, Gerald Steven, Freilich, Bradley L., Dasari, Arvind, Knisely, Benjamin T, Anderson, Marlisa, Chiang, Gary Gene, Webster, Kevin R, Sperry, Sam, Barton, Jeremy, Bendell, Johanna C.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Decrease in CA-19-9 after neoadjuvant chemoradiation therapy to predict survival in locally advanced pancreatic cancer
Singh, Jaswinder, Jafri, Syed Faisal, Pabla, Maninder, Freilich, Bradley L., Cates, Joe, Sheldon, John M., Shaeffer, David, Connor, Michael, Shah, Raj, Cope, Reed, Rath, Niharika, Burt, Michael, Mukherjee, Srijita, Parikh, Unnati, Feeback, Jennifer Wanpen
Published in Journal of clinical oncology (20.10.2012)
Published in Journal of clinical oncology (20.10.2012)
Get full text
Journal Article
Decrease in CA-19-9 after neoadjuvant chemoradiation therapy to predict survival in locally advanced pancreatic cancer
Singh, Jaswinder, Jafri, Syed Faisal, Pabla, Maninder, Freilich, Bradley L, Cates, Joe, Sheldon, John M., Shaeffer, David, Connor, Michael, Shah, Raj, Rath, Niharika, Cope, Reed, Burt, Michael, Mukherjee, Srijita, Parikh, Unnati, Feeback, Jennifer Wanpen
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article